Operating on brain gliomas by detecting the 'glow'

May 9, 2018, St. Joseph's Hospital and Medical Center

Research by Barrow Neurological Institute physicians and University of Washington scientists on novel imaging technology for malignant brain tumors was published in the April issue of World Neurosurgery. The research was conducted by Drs. Evgenii Belykh and Mark Preul at the Barrow Neurological Institute Neurosurgery Research Laboratory with technology developed by Drs. Eric Seibel and Leonard Nelson from the Department of Mechanical Engineering and the Human Photonics Laboratory at the University of Washington.

At Barrow they used a Scanning Fiber Endoscope (SFE) to detect the glow produced by adding the pro-drug 5-ALA to experimental models of . 5-ALA is metabolized in tumors to a fluorescent Porphyrin and is approved for administration to patients to increase the detection of the margin of invading brain glioma tumors, and thereby allow for a wider or more extensive brain removal. SFE allows the neurosurgeon to visualize the fluorescent light produced by 5-ALA earlier and for longer periods of time than visually possible with a standard operative microscope. SFE offers sufficient image resolution to observe individual brain and tumor cells and the scanning feature reduces the photobleaching of the fluorescent signal which can be problematic in the .

The SFE scope uses low-power laser light that is scanned with an actuator at the tip of a highly flexible shaft with overall diameter about the thickness of a nickel. For surgical guidance, two modes of imaging are generated concurrently at video rates, fluorescence to see the tumor, and reflectance imaging to see the surgical field and the surgical tools.

Drs. Seibel and Nelson commented, "The combination of high sensitivity and long viewing time of the fluorescently-labeled cancer should allow the guidance necessary for more complete tumor margin clean-up."

Drs. Belykh and Preul relate, "The advancement of this particular instrument that is the size of a pen, showing imaging on-the-fly to the surgeon as the progresses represents next generation surgical that will help brain surgeons and pathologists identify the margins of invading tumor in the operating room. Fluorescence and optical labeling techniques are increasingly used in the operating room to specifically identify and discriminate brain tumor tissues and cancers in other areas of the body. This technology is positioned to guide the surgeon's tumor resection and allow "optical biopsies" that will increase the yield of confirmatory tissue sampling. Importantly, visualization technology such as SFE should help in deciding also in where to stop the brain tumor resection. We're using incredible technology that we believe will contribute to optimizing survival for patients with gliomas and other tumors."

The research was funded by NIH R01 EB016457, PI-Seibel, Advanced biophotonics for image-guided robotic surgery, the Barrow Neurological Foundation, and the Newsome Chair in Neurosurgery Research held by Dr. Preul. Barrow is part of Dignity Health St. Joseph's Hospital and Medical Center in Phoenix.

The UW SFE technology is licensed and commercial prototypes are undergoing pre-clinical trial evaluations. Preliminary SFE imaging studies using tissue penetrating near-infrared (NIR) targeting agents have demonstrated excellent tumor contrast in animal models. Barrow and the University of Wisconsin plan to expand their collaboration into improved tumor resection using the SFE and NIR agents.

Explore further: Barrow researchers prove utility of imaging tool in surgeon's hand

Related Stories

Barrow researchers prove utility of imaging tool in surgeon's hand

May 4, 2016
Scientists at Barrow Neurological Institute have recently made discoveries about use of a new technology for imaging brain tumors in the operating room—a finding that could have important implications for identifying and ...

Researchers identify a new approach to detect the early progression of brain tumors

August 28, 2008
Researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center recently participated in a pilot study with the Montreal Neurological Institute that suggests a certain type of MRI scanning can detect ...

Study identifies new way to biopsy brain tumors in real time

November 11, 2009
A new miniature, hand-held microscope may allow more precise removal of brain tumors and an easier recognition of tumor locations during surgery.

Glowing tumors help Penn surgeons cut out brain cancer with precision

November 16, 2016
An experimental cancer imaging tool that makes tumors glow brightly during surgery has shown promise again in a new Penn Medicine clinical study, this time in patients with brain cancer. The fluorescent dye technique, originally ...

Multifunctional fluorescent nanoparticles for cancer surgery show promise

November 14, 2017
Even with pre-operative imaging techniques, surgeons still rely on visual inspection to locate malignant tissues during surgery. New research released today at the 2017 American Association of Pharmaceutical Scientists (AAPS) ...

Researchers make breakthrough on immune system and brain tumors

September 27, 2012
In what could be a breakthrough in the treatment of deadly brain tumors, a team of researchers from Barrow Neurological Institute and Arizona State University has discovered that the immune system reacts differently to different ...

Recommended for you

New drug candidate makes cancer cells more sensitive to radiotherapy

September 26, 2018
Researchers from Karolinska Institutet and Kancera AB have developed a molecule that makes cancer cells sensitive to radiotherapy. In a study published in Nature Communications, the researchers describe a new way to block ...

Aspirin could play valuable role as additional treatment for cancer

September 26, 2018
Regular use of aspirin could help in the treatment of some cancers, finds a new review of 71 medical studies.

Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

September 25, 2018
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies.

Combo therapy of prostatectomy plus radiotherapy may improve survival in prostate cancer

September 25, 2018
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective ...

Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

September 25, 2018
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for ...

Two studies describe improved approach to bone marrow transplant

September 25, 2018
Two recent studies in the journal Leukemia present a new approach for bone marrow donation and transplant that preclinical laboratory tests suggest could make the life-saving procedure safer and more effective for patients.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.